BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5740972)

  • 1. [Hepatitis during brucellosis: histologic aspects during antibotic-cortisone-vaccine therapy].
    Calonghi GF
    G Mal Infett Parassit; 1968 Mar; 20(3):297-9. PubMed ID: 5740972
    [No Abstract]   [Full Text] [Related]  

  • 2. Granulomatous hepatitis in brucellosis.
    Nagalotimath SJ; Darbar RD; Jogalekar MD
    J Indian Med Assoc; 1979 Jan; 72(1):1-4. PubMed ID: 501105
    [No Abstract]   [Full Text] [Related]  

  • 3. [The clinical picture of hepatitis in chronic brucellosis].
    Boroń P
    Wien Z Inn Med; 1968; 49(4):144-9. PubMed ID: 5737650
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current clinical aspects of brucellosis].
    De Renzi S; Cave Bondi G; Piccini A; Targetti M
    Clin Ter; 1970 Oct; 55(2):165-79. PubMed ID: 4927350
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the effect of brucella infection and of antibrucellosis therapy on vitamin B1 metabolism].
    Lopatina ZhM; Karkaliskiĭ IM; Trug AD
    Ter Arkh; 1968 Feb; 40(2):107-10. PubMed ID: 5675763
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cortisone: third element in the therapy of brucellosis; preliminary note].
    CORELLI F
    Policlinico Prat; 1955 Apr; 62(15):477-82. PubMed ID: 14384541
    [No Abstract]   [Full Text] [Related]  

  • 7. Brucellosis with kidney failure.
    Ghanei E; Miladipour A; Nasrollahi A; Homayuni M
    Iran J Kidney Dis; 2009 Apr; 3(2):109-11. PubMed ID: 19395788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brucellosis in central Anatolia: evaluation of complications and relapse.
    Naz H; Aykin N; Cevik F; Bal C
    Trop Doct; 2009 Apr; 39(2):107-9. PubMed ID: 19299298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of brucellosis in Egypt.
    MAGILL GB; KILLOUGH JH
    J Egypt Med Assoc; 1953; 36(9):447-63. PubMed ID: 13143136
    [No Abstract]   [Full Text] [Related]  

  • 10. [Induced pemphigus and brucellosis].
    Foti G; Pellicano S; Raimo C; Masseo A; Foti N
    Minerva Med; 1990; 81(1-2):107-9. PubMed ID: 2314612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of polysaccharide prodigiozan in the complex therapy of chronic and residual brucellosis].
    Kushnareva TO; Givental' NI; Andreeva PG
    Antibiotiki; 1971 Jun; 16(6):567-71. PubMed ID: 4939471
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thiamphenicol in brucellosis therapy].
    Angioni G
    G Ital Chemioter; 1968; 15(4):146-52. PubMed ID: 5744836
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neurobrucellosis].
    Sanz Moreno J; Puras Tellaeche A; Alguacil Muñoz A; Alonso Navas F; Franch O; Damiano Rivero A
    Rev Clin Esp; 1985 Apr; 176(7):349-53. PubMed ID: 4011981
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined use of antibiotics and hormonal preparations in treatment of brucellosis].
    GURSKII IuN
    Sov Med; 1959 Feb; 23(2):85-90. PubMed ID: 13646984
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical manifestations and treatment of patients with acute brucellosis caused by Br. abortus].
    Bukin VN; Tolokonskaia NP
    Klin Med (Mosk); 1981 Sep; 59(9):78-80. PubMed ID: 6796752
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic use of thiophenicol in brucellosis].
    Barba G; Bruno F
    G Ital Chemioter; 1964; 11(4):177-82. PubMed ID: 5831006
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic hepatitis and brucellosis: value of Wright's serodiagnosis. 15 cases].
    Paris J; Martin G; Gérard A; Paris JC; Merveille P; Lhermie C
    Lille Med; 1969 Oct; 14(8):873-9. PubMed ID: 5405078
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and laboratory features of brucellosis in two university hospitals in Southeast Turkey.
    Kokoglu OF; Hosoglu S; Geyik MF; Ayaz C; Akalin S; Buyukbese MA; Cetinkaya A
    Trop Doct; 2006 Jan; 36(1):49-51. PubMed ID: 16483439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined cortisone and antibiotics in therapy of brucellosis].
    DURAND P; RENOUX G
    Sem Hop; 1953 Aug 26-30; 29(52-53):2560-1. PubMed ID: 13089794
    [No Abstract]   [Full Text] [Related]  

  • 20. Azithromycin and gentamicin therapy for the treatment of humans with brucellosis.
    Solera J; Beato JL; Martínez-Alfaro E; Segura JC; de Tomas E;
    Clin Infect Dis; 2001 Feb; 32(3):506-9. PubMed ID: 11170962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.